FDA action counts
| Total FDA actions | 2 |
|---|---|
| Warning letters | 0 |
| Recalls | 2 |
| Approval records | 0 |
| Form 483 inspection citations | 0 |
| Most recent action | July 29, 2026 |
Enforcement history
On 2026-05-13, Argus HQ recorded an FDA recall for JB Chemicals and Pharmaceuticals Ltd, rated "high" severity in Argus HQ's classification: JB Chemicals and Pharmaceuticals Ltd — Class II recall: Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured…. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.
Risk pattern analysis
Argus HQ analysis — not an FDA finding
This section is Argus HQ analysis, not an FDA finding. JB Chemicals and Pharmaceuticals Ltd has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Frequently asked questions
- What is the most recent FDA action on file for JB Chemicals and Pharmaceuticals Ltd?
- July 29, 2026. Argus HQ ingests new FDA enforcement records daily.
- Has JB Chemicals and Pharmaceuticals Ltd had product recalls?
- Yes, 2 recalls on file. See the full history below for each one.
- Is this FDA enforcement data for JB Chemicals and Pharmaceuticals Ltd official?
- Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.
- How many FDA actions has JB Chemicals and Pharmaceuticals Ltd had?
- Argus HQ has recorded 1 FDA events for JB Chemicals and Pharmaceuticals Ltd: 0 warning letters, 1 recalls, 0 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Every FDA action tied to this company, the week it happens.
Free weekly briefing. Real-time alerts on paid plans.
Related enforcement actions
Compare with
- JB Chemicals and Pharmaceuticals Ltd vs Philips North America
- JB Chemicals and Pharmaceuticals Ltd vs Medline Industries, LP
- JB Chemicals and Pharmaceuticals Ltd vs Boston Scientific Corporation
- JB Chemicals and Pharmaceuticals Ltd vs Baxter Healthcare Corporation
- JB Chemicals and Pharmaceuticals Ltd vs PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Verified from FDA.gov · Last updated: Jul 29, 2026Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). Regulatory Record: JB Chemicals and Pharmaceuticals Ltd. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/company/jb-chemicals-and-pharmaceuticals-ltd
"Regulatory Record: JB Chemicals and Pharmaceuticals Ltd." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/company/jb-chemicals-and-pharmaceuticals-ltd.
Argus HQ Research. "Regulatory Record: JB Chemicals and Pharmaceuticals Ltd." Digital Empire Holdings LLC. Accessed August 29, 2026. https://argushq.ai/company/jb-chemicals-and-pharmaceuticals-ltd.
@misc{argushq_argushq_ai_company_jb_chemicals_and_pharmaceuticals_ltd_2026,
title = {Regulatory Record: JB Chemicals and Pharmaceuticals Ltd},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/company/jb-chemicals-and-pharmaceuticals-ltd},
note = {Accessed: August 29, 2026}
}Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗

